Caredx Inc (NASDAQ: CDNA) on Tuesday, plunged -3.53% from the previous trading day, before settling in for the closing price of $19.54. Within the past 52 weeks, CDNA’s price has moved between $14.09 and $34.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -137.81%. With a float of $51.92 million, this company’s outstanding shares have now reached $55.46 million.
In an organization with 650 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.46%, operating margin of 13.51%, and the pretax margin is 17.12%.
Caredx Inc (CDNA) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Caredx Inc is 6.75%, while institutional ownership is 98.60%. The most recent insider transaction that took place on Jun 18 ’25, was worth 202,566. In this transaction Director of this company sold 10,570 shares at a rate of $19.16, taking the stock ownership to the 38,994 shares. Before that another transaction happened on Jun 17 ’25, when Company’s Director sold 10,000 for $19.24, making the entire transaction worth $192,420. This insider now owns 318,846 shares in total.
Caredx Inc (CDNA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -137.81% per share during the next fiscal year.
Caredx Inc (NASDAQ: CDNA) Trading Performance Indicators
Caredx Inc (CDNA) is currently performing well based on its current performance indicators. A quick ratio of 3.84 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.03. Likewise, its price to free cash flow for the trailing twelve months is 52.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.15, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 0.17 in one year’s time.
Technical Analysis of Caredx Inc (CDNA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was better than the volume of 0.97 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.36%.
During the past 100 days, Caredx Inc’s (CDNA) raw stochastic average was set at 41.54%, which indicates a significant increase from 25.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.65% in the past 14 days, which was lower than the 63.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.70, while its 200-day Moving Average is $21.76. However, in the short run, Caredx Inc’s stock first resistance to watch stands at $19.50. Second resistance stands at $20.15. The third major resistance level sits at $20.54. If the price goes on to break the first support level at $18.46, it is likely to go to the next support level at $18.07. Assuming the price breaks the second support level, the third support level stands at $17.42.
Caredx Inc (NASDAQ: CDNA) Key Stats
Market capitalization of the company is 1.05 billion based on 55,681K outstanding shares. Right now, sales total 333,790 K and income totals 52,550 K. The company made 84,690 K in profit during its latest quarter, and -10,350 K in sales during its previous quarter.
